Ottawa – July 4, 2022 – The Canadian Centre for Ethics in Sport (CCES) announced today that Scott Lieph, a softball athlete, received a three-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during out-of-competition doping control on March 22, 2022, revealed the presence of mesterolone and oxandrolone, two prohibited anabolic agents.
On June 13, 2022, Mr. Lieph signed an Early Admission and Acceptance Agreement, thereby admitting to the violation and accepting the asserted period of ineligibility and all other consequences. As a result, the otherwise applicable four-year period of ineligibility was reduced by one year in accordance with Canadian Anti-Doping Program (CADP) rule 10.8.1. Because the athlete served a period of the provisional suspension beginning May 26, 2022, the three-year sanction terminates on May 25, 2025.
During the sanction period, the athlete, who resides in Sooke, British Columbia, is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates.
In compliance with rule 8.4 of the CADP, the CCES’s file outcome summary can be found in the Canadian Sport Sanction Registry.
About the CCES
The CCES works collaboratively to ensure Canadians have a positive sport experience. Through its programs, the CCES manages unethical issues in sport, protects the integrity of Canadian sport, and promotes True Sport to activate values-based sport on and off the field of play. The CCES is an independent, national, not-for profit organization that is responsible for the administration of the CADP. Under the CADP rules, the CCES makes public every anti-doping rule violation. For more information, visit cces.ca, follow us on X, Facebook, or Instagram.